Pre-exposure prevention of viral entry (PREVENT)
Status:
Phase:Pre-clinical
Principal Investigator(s):Jim Turpin
Objective:PREVENT (Pre-exposure prevention of viral entry) is an Integrated Preclinical/Clinical Program, with the overall goal to provide a comprehensive set of data to facilitate an informed decision on whether the antiviral lectin Griffithsin (GRFT) should progress in the topical microbicides pipeline.
Prevention Option(s):Microbicides
Study Design:
Arms and Assigned Interventions
Description
Mode of Delivery
ARMs
Official Code:
PREVENT
Trial Sponsors:
NIAID, NIH
Start Date
End Date
January 11, 2014
March 11, 2019
Enrollment:0
Age range:
↔
any
Population: